Cochrane Abstracts
Additional bedtime H2-receptor antagonist for the control of nocturnal gastric acid breakthrough: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Additional Bedtime H2-receptor Antagonist for the Control of Nocturnal Gastric Acid Breakthrough: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437974/all/Biologic_interventions_for_fatigue_in_rheumatoid_arthritis_New. Accessed 29 November 2023.
Additional bedtime H2-receptor antagonist for the control of nocturnal gastric acid breakthrough: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437974/all/Biologic_interventions_for_fatigue_in_rheumatoid_arthritis_New. Accessed November 29, 2023.
Additional bedtime H2-receptor antagonist for the control of nocturnal gastric acid breakthrough: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/437974/all/Biologic_interventions_for_fatigue_in_rheumatoid_arthritis_New
Additional Bedtime H2-receptor Antagonist for the Control of Nocturnal Gastric Acid Breakthrough: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2023 November 29]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437974/all/Biologic_interventions_for_fatigue_in_rheumatoid_arthritis_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Additional bedtime H2-receptor antagonist for the control of nocturnal gastric acid breakthrough: Cochrane systematic review
ID - 437974
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437974/all/Biologic_interventions_for_fatigue_in_rheumatoid_arthritis_New
DB - Evidence Central
DP - Unbound Medicine
ER -
